Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children

Lengyue Peng1, Yawen Gao1, Guangli Zhang1

  • 1Department of Respiratory Medicine Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.

Insights

Continuous venovenous hemofiltration (CVVH) in critically ill children may increase vancomycin trough concentrations, leading to supratherapeutic levels. High Pediatric Risk of Mortality (PRISM) III scores are linked to these elevated levels.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacokinetics
  • Nephrology

Background:

  • Vancomycin trough concentrations are crucial for clinical outcomes and minimizing adverse drug effects in critically ill patients.
  • Understanding factors influencing vancomycin levels is essential for optimizing therapy in vulnerable pediatric populations.

Purpose of the Study:

  • To investigate the impact of continuous venovenous hemofiltration (CVVH) on vancomycin trough concentrations in critically ill children.
  • To identify risk factors associated with supratherapeutic vancomycin trough concentrations during CVVH therapy.

Main Methods:

  • Retrospective analysis of critically ill children (January 2016-December 2019) with steady-state vancomycin trough concentrations.
  • Patients were categorized into CVVH and non-CVVH groups based on treatment and renal function.
  • Comparison of vancomycin trough concentrations and logistic regression analysis for risk factors of supratherapeutic levels (>20 mg/L).

Main Results:

  • The CVVH group (n=35) exhibited significantly higher median vancomycin trough concentrations compared to the non-CVVH group (n=84) [14.9 vs. 9.3 mg/L].
  • While therapeutic concentrations (10-20 mg/L) were similar, the CVVH group had a higher proportion of supratherapeutic concentrations (20.0% vs. 1.2%).
  • Pediatric Risk of Mortality (PRISM) III score ≥28 was identified as an independent risk factor for supratherapeutic vancomycin trough concentrations (OR =13.7).

Conclusions:

  • Continuous venovenous hemofiltration (CVVH) therapy significantly influences vancomycin trough concentrations in critically ill children, increasing the risk of supratherapeutic levels with a 40-60 mg/kg/day dosage.
  • Elevated Pediatric Risk of Mortality (PRISM) III scores (≥28) are independently associated with supratherapeutic vancomycin trough concentrations in pediatric patients undergoing CVVH.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
52
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
331
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
82
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
98
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
86
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
79